⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL361040 | 0.93 | — | — | |
| SCHEMBL8109972 | 0.87 | — | — | |
| SCHEMBL37019 | 0.79 | — | — | |
| SCHEMBL12513244 | 0.79 | — | — | |
| SCHEMBL12060984 | 0.79 | — | — | |
| SCHEMBL28290144 | 0.76 | — | — | |
| SCHEMBL7898760 | 0.73 | — | — | |
| SCHEMBL342544 | 0.73 | NOS2 (0.33) | — | |
| SCHEMBL896226 | 0.72 | — | — | |
| SCHEMBL12060989 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3965884-A1 | MODULATORS OF THR-BETA AND METHODS OF USE THEREOF | Aligos Therapeutics, Inc. (US) | 2022-03-16 | — | — | EP | claimed |
| US-11091467-B2 | Modulators of THR-β and methods of use thereof | ALIGOS THERAPEUTICS, INC. (US) | 2021-08-17 | — | — | US | claimed |
| US-20210177811-A1 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | CALLIDITAS THERAPEUTICS SUISSE SA (CH) | 2021-06-17 | — | — | US | claimed |
| US-20200354345-A1 | MODULATORS OF THR-BETA AND METHODS OF USE THEREOF | ALIGOS THERAPEUTICS, INC. (US) | 2020-11-12 | — | — | US | claimed |
| WO-2020227549-A1 | MODULATORS OF THR-β AND METHODS OF USE THEREOF | ALIGOS THERAPEUTICS, INC. (US) | 2020-11-12 | — | — | WO | claimed |
| CN-111344013-A | Use of NOX inhibitors for the treatment of cancer | 吉恩基奥泰克斯瑞士股份有限公司 | 2020-06-26 | — | — | CN | claimed |
| US-20200048240-A1 | ACYL SULFONAMIDE NAV1.7 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2020-02-13 | — | — | US | claimed |
| EP-3532462-A1 | ACYL SULFONAMIDE NAV1.7 INHIBITORS | Bristol-Myers Squibb Company (US) | 2019-09-04 | — | — | EP | claimed |
| EP-3479843-A1 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | GenKyoTex Suisse SA (CH) | 2019-05-08 | — | — | EP | claimed |
| WO-2018081384-A1 | ACYL SULFONAMIDE NAV1.7 INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-03 | — | — | WO | claimed |
| WO-1994029281-A1 | CYCLOBUTYLAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 1994-12-22 | — | — | WO | claimed |
| EP-0603240-A1 | SAFENING HERBICIDAL PYRAZOLYLSULFONYLURES | MONSANTO COMPANY (US) | 1994-06-29 | — | — | EP | claimed |
| EP-0562015-A1 | SAFENED HERBICIDAL SULFONAMIDE COMPOSITIONS | MONSANTO COMPANY (US) | 1993-09-29 | — | — | EP | claimed |
| WO-1993003615-A1 | SAFENING HERBICIDAL PYRAZOLYLSULFONYLURES | MONSANTO COMPANY (US) | 1993-03-04 | — | — | WO | claimed |
| WO-1992010098-A1 | SAFENED HERBICIDAL SULFONAMIDE COMPOSITIONS | MONSANTO COMPANY (US) | 1992-06-25 | — | — | WO | claimed |
| EP-0419963-A2 | 1,2,3,4-Tetrahydro-5-nitropyrimidine derivatives | BAYER AG (DE) | 1991-04-03 | — | — | EP | claimed |
| EP-0355544-A2 | Substituted decalin amines, method for their preparation and their use in pesticides | BAYER AG (DE) | 1990-02-28 | — | — | EP | claimed |
| EP-0355540-A2 | Substituted cyclohexyl amines, process for their preparation and their use as pesticides | BAYER AG (DE) | 1990-02-28 | — | — | EP | claimed |
| EP-0294666-A2 | Substituted triazolinones | BAYER AG (DE) | 1988-12-14 | — | — | EP | claimed |
| EP-0002939-A2 | Novel carbothioamides, compositions containing them and their preparation | ELI LILLY AND COMPANY (US) | 1979-07-11 | — | — | EP | claimed |